FYI: FDA habla español

Share this article:

The FDA's watchdogs are putting their language skills to use. Regulatory Focus reports that the regulator issued a Warning Letter to website owner Ramon Rosa for misbranding his products.

Rosa claimed his drugs could treat illnesses including cancer, ringworm, diabetes and arthritis, and the FDA says it has not approved these claims. What makes this Warning Letter different is that it is about materials written in Spanish.

RF notes that the majority of the FDA's promotional monitoring focuses on English language promos, but that it has the authority to review Spanish-language materials if they are published in Puerto Rico—which is where Rosa is based.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.